Navigation Links
Press registration is now open for EULAR 2011, May 25-28, London
Date:2/28/2011

Press registration is free of charge for all holders of a valid press card / formal journalist credentials. Press will have access to the onsite press facilities, including a working room and an interview room. The Press Office staff will also be able to assist you in organising interviews with relevant experts.

EULAR is one of the foremost international medical meetings in rheumatology and receives an attendance of over 12,000 delegates and 300 members of the press each year. The congress will cover the full spectrum of the rheumatic diseases, from new data to basic science, clinical symposia, abstract sessions, presentation and discussion of difficult cases, workshops, special interest group sessions and state-of-the-art lectures.

Press materials will select key newsworthy stories, from new clinical trial data to the social issues associated with rheumatologic conditions, along with specific stories on paediatric rheumatology. Several press conferences will be held during EULAR timings to be confirmed.

We look forward to seeing you at EULAR 2011 in London.


'/>"/>

Contact: Rory Berrie
rory.berrie@cohnwolfe.com
44-207-331-5317
European League Against Rheumatism
Source:Eurekalert

Page: 1

Related biology news :

1. European Multidisciplinary Conference in Thoracic Oncology -- press program
2. Press registration open for clinical nutrition conference
3. Groundbreaking technology will revolutionize blood pressure measurement
4. Media alert: ACMG 2011 Clinical Genetics Meeting -- press registration is now open
5. Cell Press wins prestigious PROSE Award for Article of the Future
6. A second pathway for antidepressants
7. Scientific research reveals brain alterations linking omega 3 deficit with depression
8. New clue to lupus: Failed autoimmune suppression mechanism
9. A deficiency of dietary omega-3 may explain depressive behaviors
10. Common antibiotics and blood pressure medication may result in hospitalization
11. MicroRNA suppresses prostate cancer stem cells and metastasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... , June 22, 2016   ... management and verification solutions, has partnered with ... software solutions for Visitor Management, Self-Service Kiosks ... provides products that add functional enhancements to ... provides corporations and venues with an automated ...
(Date:6/16/2016)... FRANCISCO , June 16, 2016 ... size is expected to reach USD 1.83 ... by Grand View Research, Inc. Technological proliferation and ... banking applications are expected to drive the market ... ) , The development of advanced ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... have just published their findings on what they believe could be a new ... summary of the new research. Click here to read it now. ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology: